Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Allen

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|May 6, 2026
Factors Associated With Menopause Symptoms: A Systematic Review and Meta-AnalysisJanice Hoang, Kathryn Halliday, Deborah Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Psicologia, Reflexao E Critica : Revista Semestral Do Departamento De Psicologia Da UFRGS|February 7, 2020
Needs assessment for cultural adaptation of Strengthening Families Program (SFP 10-14-UK) in BrazilSheila Giardini Murta, Larissa de Almeida Nobre-Sandoval, Marina de Souza Pedralho, et al.
Breast Cancer Research and Treatment|October 8, 2020
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevantKarina Cox, Nicky Dineen, Sian Taylor-Phillips, et al.
Journal of Oncology Practice|August 11, 2017
Improvements in Patient and Health System Outcomes Using an Integrated Oncology and Palliative Medicine Approach on a Solid Tumor Inpatient ServiceRichard F Riedel, Kim Slusser, Steve Power, et al.
Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Cediranib for metastatic alveolar soft part sarcomaShivaani Kummar, Deborah Allen, Anne Monks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumorsShivaani Kummar, Mark Raffeld, Lamin Juwara, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasShivaani Kummar, Martin E Gutierrez, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomasShivaani Kummar, Jiuping Ji, Robert Morgan, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
BJOG : an International Journal of Obstetrics and Gynaecology|May 6, 2026
Factors Associated With Menopause Symptoms: A Systematic Review and Meta-AnalysisJanice Hoang, Kathryn Halliday, Deborah Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Psicologia, Reflexao E Critica : Revista Semestral Do Departamento De Psicologia Da UFRGS|February 7, 2020
Needs assessment for cultural adaptation of Strengthening Families Program (SFP 10-14-UK) in BrazilSheila Giardini Murta, Larissa de Almeida Nobre-Sandoval, Marina de Souza Pedralho, et al.
Breast Cancer Research and Treatment|October 8, 2020
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevantKarina Cox, Nicky Dineen, Sian Taylor-Phillips, et al.
Journal of Oncology Practice|August 11, 2017
Improvements in Patient and Health System Outcomes Using an Integrated Oncology and Palliative Medicine Approach on a Solid Tumor Inpatient ServiceRichard F Riedel, Kim Slusser, Steve Power, et al.
Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Cediranib for metastatic alveolar soft part sarcomaShivaani Kummar, Deborah Allen, Anne Monks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumorsShivaani Kummar, Mark Raffeld, Lamin Juwara, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasShivaani Kummar, Martin E Gutierrez, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomasShivaani Kummar, Jiuping Ji, Robert Morgan, et al.
Pageof 10